| Autor: |
Graindorge, E., Francotte, P., Boverie, S., Tullio, P. de, Pirotte, B. |
| Zdroj: |
Current Medicinal Chemistry - Central Nervous System Agents; June 01, 2004, Vol. 4 Issue: 2 p95-103, 9p |
| Abstrakt: |
The 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propanoic acid (AMPA) receptors, a subtype of glutamate receptors, are involved in important neuronal functions such as long-term memory. A decrease of the number and activity of these receptors seems to play a role in schizophrenia and in the impairment of cognitive function associated to Alzheimer's disease. Therefore, research has been focused on the development of drugs acting on those receptors, in particular of AMPA receptors positive allosteric modulators. Although agonists have an intrinsic activity, allosteric modulators need the release of glutamate to be active. Therefore, these drugs are expected to exhibit a decreasing risk of toxicity compared to pure agonists. In this article, we review the recent advances in the design of positive allosteric modulators of AMPA receptors. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
